Skip to main content
Erschienen in: International Ophthalmology 6/2020

05.02.2020 | Original Paper

Early changes of vascular lesions and responses to combined photodynamic therapy in patients with polypoidal choroidal vasculopathy

verfasst von: Kimiko Asano-Shimizu, Shotaro Asano, Hiroshi Murata, Keiko Azuma, Yoko Nomura, Tatsuya Inoue, Asako Ogawa, Ryo Asaoka, Ryo Obata

Erschienen in: International Ophthalmology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate early changes of vascular lesions and their associations with the early responses to combined photodynamic therapy (PDT) in eyes with polypoidal choroidal vasculopathy (PCV).

Methods

This study evaluated 19 eyes of 19 patients with PCV who underwent PDT combined with anti-vascular endothelial growth factor injections and were followed for 3 months. All subjects were examined 1 week and 1, 2, and 3 months after combined PDT. “Active” cases were defined as recurrence or persistence of serous retinal detachment or subretinal hemorrhage detected within 3 months. Branching vascular networks (BVNs) were evaluated by optical coherence tomography angiography (OCTA) and polyps by indocyanine-green angiography.

Results

In total, 16%, 58%, 84%, and 89% of eyes displayed BVNs 1 week, 1, 2, and 3 months after PDT, respectively. BVNs were detected significantly more often 1 month after PDT in the “active” group than “inactive” group (89% vs. 30%, p = 0.020). There were significantly higher overall proportions of BVNs detected by OCTA in the “active” group than “inactive” group (p = 0.0058).

Conclusion

In most cases, BVNs disappeared once and gradually appeared again within 3 months. Detecting BVNs using OCTA from early phases could be a helpful biomarker to assess the early responses to PDT in eyes with PCV.
Literatur
1.
Zurück zum Zitat Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (2012) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 32(Suppl 1):1–8PubMed Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (2012) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 32(Suppl 1):1–8PubMed
10.
Zurück zum Zitat Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32(8):1453–1464. https://doi.org/10.1097/IAE.0b013e31824f91e8 CrossRefPubMed Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32(8):1453–1464. https://​doi.​org/​10.​1097/​IAE.​0b013e31824f91e8​ CrossRefPubMed
30.
Zurück zum Zitat Gomi F, Oshima Y, Mori R, Kano M, Saito M, Yamashita A, Iwata E, Maruko R, Fujisan Study G (2015) Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study. Retina 35(8):1569–1576CrossRef Gomi F, Oshima Y, Mori R, Kano M, Saito M, Yamashita A, Iwata E, Maruko R, Fujisan Study G (2015) Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study. Retina 35(8):1569–1576CrossRef
Metadaten
Titel
Early changes of vascular lesions and responses to combined photodynamic therapy in patients with polypoidal choroidal vasculopathy
verfasst von
Kimiko Asano-Shimizu
Shotaro Asano
Hiroshi Murata
Keiko Azuma
Yoko Nomura
Tatsuya Inoue
Asako Ogawa
Ryo Asaoka
Ryo Obata
Publikationsdatum
05.02.2020
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 6/2020
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-020-01299-3

Weitere Artikel der Ausgabe 6/2020

International Ophthalmology 6/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.